I N V E S T O R   O P P O R T U N I T I E S

The Neuro-Cells® technology platform addresses therapeutic areas for which no effective treatment exist and that pressure healthcare expenditure. Our primary focus are neurodegenerative diseases and Traumatic Spinal Cord Injury (TSCI) specifically. However, preclinical evidence suggests much broader applicability of the technology to other neurological disorders. Furthermore, we hold an Orphan Disease Designation that enables fast track development.

We value our stakeholders and invite you to become part of our mission to give back perspective.

Please contact us via Vincent The (v.the@neuroplast.com)